Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy

British Journal of Haematology

Volumn 143, Issue 5, 2008, Pages 738-743

  Kao, Susan Y ^a   Xu, Wei ^a   Brandwein, Joseph M ^a   Lipton, Jeffrey H ^a   Messner, Hans A ^a   Minden, Mark D ^a   Schimmer, Aaron D ^a   Schuh, Andre C ^a   Yee, Karen ^a   Gupta, Vikas ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Antithymocyte globulin; Aplastic anaemia; Ciclosporin; Elderly; Immunosuppressive therapy

Indexed keywords

CYCLOSPORIN A; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG TOLERABILITY; DRUG TOXICITY; FEMALE; HEART DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOTHERAPY; MORTALITY; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; SURVIVAL; TREATMENT RESPONSE;

AGED; ANEMIA, APLASTIC; ANIMALS; ANTILYMPHOCYTE SERUM; CHI-SQUARE DISTRIBUTION; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 55949136059     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07389.x     Document Type: Article

References (18)

1. Bacigalupo, A., Hows, J., Gluckman, E., Nissen, C., Marsh, J., Van Lint, M.T., Congiu, M., De Planque, M.M., Ernst, P., McCann, S., Ragavashar, A., Frickhofen, N., Wursch, A., Marmont, A.M. Gordon-Smith, E.C. (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. British Journal of Haematology, 70, 177 182.
2. Bottiger, L.E. (1979) Epidemiology and aetiology of aplastic anemia. Haematology and Blood Transfusion, 24, 27 37.
3. Camitta, B.M. (2000) What is the definition of cure for aplastic anemia? Acta Haematologica, 103, 16 18.
4. Camitta, B.M., Thomas, E.D., Nathan, D.G., Santos, G., Gordon-Smith, E.C., Gale, R.P., Rappeport, J.M. Storb, R. (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood, 48, 63 70.
5. Charlson, M.E., Pompei, P., Ales, K.L. MacKenzie, C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases, 40, 373 383.
6. Davies, S.M. Walker, D.J. (1986) Aplastic anaemia in the Northern Region 1971-1978 and follow-up of long term survivors. Clinical and Laboratory Haematology, 8, 307 313.
7. Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, F., Freund, M., Meusers, P., Salama, A. Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New England Journal of Medicine, 324, 1297 1304.
8. Frickhofen, N., Heimpel, H., Kaltwasser, J.P. Schrezenmeier, H. (2003) Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood, 101, 1236 1242.
9. Gooley, T.A., Leisenring, W., Crowley, J. Storer, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695 706.
10. International Agranulocytosis and Aplastic Anemia Study 1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood, 70, 1718 1721.
11. Killick, S.B., Cavenagh, J.D., Davies, J.K. Marsh, J.C. (2006) Low dose antithymocyte globulin for the treatment of older patients with aplastic anaemia. Leukemia Research, 30, 1517 1520.
12. Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J. Fuhrer, M. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 92, 11 18.
13. Marsh, J., Schrezenmeier, H., Marin, P., Ilhan, O., Ljungman, P., McCann, S., Socie, G., Tichelli, A., Passweg, J., Hows, J., Raghavachar, A., Locasciulli, A. Bacigalupo, A. (1999) Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood, 93, 2191 2195.
14. Mary, J.Y., Baumelou, E. Guiguet, M. (1990) Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood, 75, 1646 1653.
15. Montane, E., Ibanez, L., Vidal, X., Ballarin, E., Puig, R., Garcia, N. Laporte, J.R. (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica, 93, 518 523.
16. Rosenfeld, S., Follmann, D., Nunez, O. Young, N.S. (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA, 289, 1130 1135.
17. Tichelli, A., Socie, G., Henry-Amar, M., Marsh, J., Passweg, J., Schrezenmeier, H., McCann, S., Hows, J., Ljungman, P., Marin, P., Raghavachar, A., Locasciulli, A., Gratwohl, A. Bacigalupo, A. (1999) Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Annals of Internal Medicine, 130, 193 201.
18. Wiktor, A., Rybicki, B.A., Piao, Z.S., Shurafa, M., Barthel, B., Maeda, K. Van Dyke, D.L. (2000) Clinical significance of Y chromosome loss in hematologic disease. Genes, Chromosomes and Cancer, 27, 11 16.